UK Markets closed

Iovance Biotherapeutics, Inc. (0JDK.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
24.48+0.40 (+1.66%)
At close: 2:39PM BST
Full screen
Previous close24.08
Bid0.00 x 0
Ask0.00 x 0
Day's range24.48 - 24.48
52-week range24.48 - 24.48
Avg. volumeN/A
Market cap3.296B
Beta (5Y monthly)0.82
PE ratio (TTM)N/A
EPS (TTM)-1.88
Earnings date03 Nov 2021 - 08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Iovance Is Up Nearly 11% Today

    Shares of biopharma company Iovance (NASDAQ: IOVA) are poised to end Wednesday's trading session almost 11% higher than Tuesday's close, following an encouraging observation from investment analytics outfit Truist. Namely, the odds of an approval of one of its drug prospects seemingly improved after a rival drug developer was granted permission to expand its trials of a similar therapy. On Monday, Instil Bio (NASDAQ: TIL) announced the Food and Drug Administration had cleared the company's request to widen the scope of its current phase 2 trial of ITIL-168.

  • Zacks

    Implied Volatility Surging for Iovance (IOVA) Stock Options

    Investors need to pay close attention to Iovance (IOVA) stock based on the movements in the options market lately.

  • Zacks

    Iovance (IOVA) Q2 Earnings Miss Estimates, Pipeline in Focus

    Iovance's (IOVA) second-quarter loss is wider than expected. The company is progressing well in terms of development of its pipeline candidates.